| How to improve R&D productivity: the pharmaceutical industry's grand challenge SM Paul, DS Mytelka, CT Dunwiddie, CC Persinger, BH Munos, ... Nature reviews Drug discovery 9 (3), 203-214, 2010 | 4306 | 2010 |
| Lessons from 60 years of pharmaceutical innovation B Munos Nature reviews Drug discovery 8 (12), 959, 2009 | 1543 | 2009 |
| Can open-source R&D reinvigorate drug research? B Munos Nature Reviews Drug Discovery 5 (9), 723-729, 2006 | 178 | 2006 |
| Mobile health: the power of wearables, sensors, and apps to transform clinical trials B Munos, PC Baker, BM Bot, M Crouthamel, G de Vries, I Ferguson, ... Annals of the New York Academy of Sciences 1375 (1), 3-18, 2016 | 129 | 2016 |
| How to revive breakthrough innovation in the pharmaceutical industry BH Munos, WW Chin Science translational medicine 3 (89), 89cm16-89cm16, 2011 | 120 | 2011 |
| Towards new business models for R&D for novel antibiotics AD So, N Gupta, SK Brahmachari, I Chopra, B Munos, C Nathan, ... Drug Resistance Updates 14 (2), 88-94, 2011 | 103 | 2011 |
| Can Open‐Source Drug R&D Repower Pharmaceutical Innovation? B Munos Clinical Pharmacology & Therapeutics 87 (5), 534-536, 2010 | 96 | 2010 |
| Time for NIH to lead on data sharing I Sim, M Stebbins, BE Bierer, AJ Butte, J Drazen, V Dzau, AF Hernandez, ... Science 367 (6484), 1308-1309, 2020 | 48 | 2020 |
| A call for sharing: adapting pharmaceutical research to new realities BH Munos, WW Chin Science Translational Medicine 1 (9), 9cm8-9cm8, 2009 | 45 | 2009 |
| A forensic analysis of drug targets from 2000 through 2012 B Munos Clinical Pharmacology & Therapeutics 94 (3), 407-411, 2013 | 27 | 2013 |
| Pharmaceutical innovation gets a little help from new friends BH Munos Science Translational Medicine 5 (168), 168ed1-168ed1, 2013 | 19 | 2013 |
| Disruptive innovation and transformation of the drug discovery and development enterprise BH Munos, JJ Orloff NAM Perspectives, 2016 | 14 | 2016 |
| Improving the prediction of clinical success using machine learning B Munos, J Niederreiter, M Riccaboni medRxiv, 2021.02. 01.21250864, 2021 | 9 | 2021 |
| Biomedical innovation: lessons from the past and perspectives for the future BH Munos Clinical Pharmacology & Therapeutics 100 (6), 588-590, 2016 | 8 | 2016 |
| How to handle an industry in disruption: Intervene or laissez-faire? B Munos Science Translational Medicine 7 (286), 286ps12-286ps12, 2015 | 6 | 2015 |
| Accelerating innovation in the bioscience revolution BH Munos Collaborative Innovation in Drug Discovery, 195-212, 2014 | 5 | 2014 |
| How To Avert Biopharma's R&D Crisis B Munos In Vivo-Business and Medicine Report 29 (3), 58, 2011 | 5 | 2011 |
| Harnessing Open Innovation to Tackle the Dearth of Novel Antibiotics B Munos ReAct, 2011 | 2 | 2011 |
| Annals Reports B Munos, PC Baker, BM Bot, M Crouthamel, G de Vries, I Ferguson, ... | | 2016 |
| How to beat back the commoditzation of the pharmaceutical industry? B Munos ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 242, 2011 | | 2011 |
